GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$81.76 -1.16 (-1.40%)

(As of 11/15/2024 ET)

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
1

Hold
5

Buy
9

Based on 15 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a sell rating, 5 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$94.36
15.41% Upside

According to the 15 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $94.36. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $74.00. The average price target represents a forecasted upside of 15.41% from the current price of $81.76.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

GEHC Analyst Ratings Over Time

Type	Current Forecast 11/18/23 to 11/17/24	1 Month Ago 10/19/23 to 10/18/24	3 Months Ago 8/20/23 to 8/19/24	1 Year Ago 11/18/22 to 11/18/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$94.36	$94.23	$95.00	$88.44
Forecasted Upside	15.41% Upside	3.16% Upside	10.99% Upside	21.16% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

5 Stocks that could triple in a week (Ad)

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.60	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	15.41% Upside	28,591.96% Upside	9.87% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/31/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$95.00 ➝ $96.00	+9.90%
10/1/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$98.00 ➝ $102.00	+10.82%
9/30/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Buy ➝ Buy	$100.00 ➝ $102.00	+10.88%
9/26/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Doyle Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$84.00 ➝ $74.00	-20.44%
9/18/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00	+15.22%
9/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$90.00	+5.77%
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$87.00	+10.90%
5/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$94.00 ➝ $86.00	+10.45%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$110.00 ➝ $105.00	+35.45%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$88.00 ➝ $103.00	+14.62%
4/1/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $110.00	+22.82%
2/15/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.24%
2/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$74.00 ➝ $86.00	+3.40%
11/30/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$80.00	+18.15%
5/15/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$97.00	+29.45%
4/19/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$95.00	+13.55%
1/19/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
1/4/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:31 AM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 28, 2024. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

GE HealthCare Technologies Inc. has recently announced a quarterly dividend of $0.03 per share, providing investors with a steady income stream.
BTIG Research upgraded GE HealthCare Technologies from a "neutral" to a "buy" rating with a price target of $100.00, indicating potential for stock price appreciation.
GE HealthCare Technologies reported earnings per share of $1.00 for the last quarter, surpassing analyst estimates, showcasing strong financial performance.
The company's return on equity stands at 25.26%, indicating efficient utilization of shareholder funds to generate profits.
GE HealthCare Technologies Inc. has a consensus rating of "Moderate Buy" with a price target of $93.92, suggesting positive sentiment from analysts and potential growth.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

UBS Group downgraded GE HealthCare Technologies from a "neutral" to a "sell" rating, indicating potential concerns about the company's performance.
The stock price of GE HealthCare Technologies Inc. has decreased by 0.5% recently, which may raise doubts about short-term stock performance.
GE HealthCare Technologies Inc. has a debt-to-equity ratio of 1.05, suggesting a relatively high level of debt that could impact financial stability.
Stifel Nicolaus initiated coverage on GE HealthCare Technologies with a "buy" rating, but the stock has a beta of 1.17, indicating higher volatility compared to the market.
One research analyst has rated the stock as a sell, indicating some negative sentiment in the market towards GE HealthCare Technologies Inc.

GEHC Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $94.36, with a high forecast of $110.00 and a low forecast of $74.00.
: 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There is currently 1 sell rating, 5 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEHC shares.
: According to analysts, GE HealthCare Technologies's stock has a predicted upside of 15.41% based on their 12-month stock forecasts.
: Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade and 1 downgrade by analysts.
: GE HealthCare Technologies has been rated by research analysts at BTIG Research, Evercore ISI, JPMorgan Chase & Co., Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.60 while the average consensus rating score for "medical" companies is 2.80. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>

This page (NASDAQ:GEHC) was last updated on 11/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target